← Leaderboards
Hui-Chen Lu
Baylor College Of Medicine
$10,972,069
Attributed
$12,274,162
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,274,162 · 7
By mechanism
R01$9,824,772 · 3
P30$1,476,579 · 1
R21$819,199 · 2
F32$153,612 · 1
Top collaborators
- Kenneth P. Mackie8 shared
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Arun Sreekumar$9,871,133
- Ganesh S Palapattu$5,706,843
- Nagireddy Putluri$4,166,248
- Javier A Sanchez$66,781
- Gregg W Roman$3,671,791
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposBrainNeuronsPlayInsightPublic Health RelevanceGlutamatesPreventLifeEnzymesChronicMolecularImpairmentTherapy DevelopmentIn VivoKnockout MiceEndocannabinoidsProteinsSynapsesMaintenanceImageMediatingProgramsDefect
Grant awards (39)
Molecular and genetic studies of NMNAT2 in neuroprotection$462,158
R01 · FY2025 · NS · contact PI
Multi-Scale Imaging Core (MSIC)$451,319
P30 · FY2025 · DA · contact PI
Mechanisms and treatment of adolescent phytocannabinoid impairment of prefrontal cortex function$427,962
R01 · FY2025 · DA · contact PI
Molecular and genetic studies of NMNAT2 in neuroprotection$507,169
R01 · FY2024 · NS · contact PI
Multi-Scale Imaging Core (MSIC)$451,319
P30 · FY2024 · DA · contact PI
Mechanisms and treatment of adolescent phytocannabinoid impairment of prefrontal cortex function$427,962
R01 · FY2024 · DA · contact PI
Molecular and genetic studies of NMNAT2 in neuroprotection$56,835
R01 · FY2024 · NS · contact PI
Multi-Scale Imaging Core (MSIC)$573,941
P30 · FY2023 · DA · contact PI
Molecular and genetic studies of NMNAT2 in neuroprotection$512,710
R01 · FY2023 · NS · contact PI
Mechanisms and treatment of adolescent phytocannabinoid impairment of prefrontal cortex function$440,092
R01 · FY2023 · DA · contact PI
Molecular and genetic studies of NMNAT2 in neuroprotection$56,558
R01 · FY2023 · NS · contact PI
Molecular and genetic studies of NMNAT2 in neuroprotection$591,356
R01 · FY2022 · NS · contact PI
Mechanisms and treatment of adolescent phytocannabinoid impairment of prefrontal cortex function$488,971
R01 · FY2022 · DA · contact PI
Molecular and genetic studies of NMNAT2 in neuroprotection$69,553
R01 · FY2022 · NS · contact PI
Molecular and genetic studies of NMNAT2 in neuroprotection$563,912
R01 · FY2021 · NS · contact PI
Molecular and genetic studies of NMNAT2 in neuroprotection$50,000
R01 · FY2019 · NS · contact PI
Molecular and genetic studies of NMNAT2 in neuroprotection$406,293
R01 · FY2018 · NS · contact PI
Molecular and genetic studies of NMNAT2 in neuroprotection$421,751
R01 · FY2017 · NS · contact PI
Molecular and genetic studies of NMNAT2 in neuroprotection$427,201
R01 · FY2016 · NS · contact PI
Molecular and genetic studies of NMNAT2 in neuroprotection$424,067
R01 · FY2015 · NS · contact PI
Signaling Cascades in Sensory Map Development$341,250
R01 · FY2015 · NS · contact PI
Molecular and genetic studies of NMNAT2 in neuroprotection$421,563
R01 · FY2014 · NS · contact PI
Signaling cascades in sensory map development$340,654
R01 · FY2014 · NS · contact PI
Molecular and genetic studies of NMNAT2 in neuroprotection$23,115
R01 · FY2014 · NS · contact PI
Signaling cascades in sensory map development$332,051
R01 · FY2013 · NS · contact PI
Signaling cascades in sensory map development$344,094
R01 · FY2012 · NS · contact PI
Signaling cascades in sensory map development$344,094
R01 · FY2011 · NS · contact PI
Will therapeutic dosing of fatty acid amino hydrolase inhibitors disrupt neuronal$221,400
R21 · FY2011 · HD
Do organophosphates impair neurodevelopment through inhibition of endocannabinoid$186,423
R21 · FY2011 · DA
Will therapeutic dosing of fatty acid amino hydrolase inhibitors disrupt neuronal$205,688
R21 · FY2010 · HD
Do organophosphates impair neurodevelopment through inhibition of endocannabinoid$205,688
R21 · FY2010 · DA
cAMP Signaling Cascades in Sensory Map Development$328,901
R01 · FY2008 · NS · contact PI
cAMP Signaling Cascades in Sensory Map Development$328,901
R01 · FY2007 · NS · contact PI
cAMP Signaling Cascades in Sensory Map Development$338,724
R01 · FY2006 · NS · contact PI
cAMP Signaling Cascades in Sensory Map Development$346,875
R01 · FY2005 · NS
ADENYLYL CYCLASE IN BARREL CORTEX DEVELOPMENT$25,952
F32 · FY2003 · NS
ADENYLYL CYCLASE IN BARREL CORTEX DEVELOPMENT$48,148
F32 · FY2002 · NS
ADENYLYL CYCLASE IN BARREL CORTEX DEVELOPMENT$41,996
F32 · FY2001 · NS
ADENYLYL CYCLASE IN BARREL CORTEX DEVELOPMENT$37,516
F32 · FY2000 · NS